Earnings Recap – February 2nd
AbbVie reported Q4 earnings on Wednesday. The American biopharmaceutical technology company reported adjusted earnings of $3.31 per share, beating analysts’ expectations of $3.28 per share. Revenue was $14.8 billion, missing analysts’ expectations of $14.9 billion. For fiscal 2022, the company said it expects adjusted earnings between $14.00 and $14.20 per share.
Marathon Petroleum reported Q4 earnings on Wednesday. The American oil company reported earnings of $1.30 per share, beating analysts’ expectations of $0.47 per share. Revenue grew 95% from last year to $35.61 billion. Over the previous four quarters, Marathon has surpassed consensus revenue projections four times.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.